Ge (Gina) Wei
San Francisco, California, United States
1K followers
500 connections
San Francisco, California, United States
1K followers
500 connections
About
A seasoned drug development leader with experience in drug discovery and late-stage…
Activity
-
Today, I would like to honor the memory of Roger Y. Tsien, who died on August 24, 2016. His legacy lives with all who use his technologies, including…
Today, I would like to honor the memory of Roger Y. Tsien, who died on August 24, 2016. His legacy lives with all who use his technologies, including…
Liked by Ge (Gina) Wei
-
NX-1607: First-in-Class Inhibitor of CBL-B for Immuno-Oncology | https://lnkd.in/gYDqQPKh Thu, Aug 29, 2024 8 AM PDT / 11 AM EDT / 5 PM CEST LIVE…
NX-1607: First-in-Class Inhibitor of CBL-B for Immuno-Oncology | https://lnkd.in/gYDqQPKh Thu, Aug 29, 2024 8 AM PDT / 11 AM EDT / 5 PM CEST LIVE…
Liked by Ge (Gina) Wei
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
UC Santa Barbara Extension
-
-
Activities and Societies: Member of American Society of Cell Biology Member of Society of Glycobiolgy
Advisor: Professor and Dr. Jeffrey D. Esko
Thesis title: Glucuronosyltransferases in Heparan Sulfate Initiation and Polymerization -
-
Licenses & Certifications
-
-
Project Management Certificate
Ignyta
Issued
Volunteer Experience
-
Volunteer
Young Men's Service League National- Official LinkedIn for Members and Alumni
- Present 4 years 4 months
-
Languages
-
English
Native or bilingual proficiency
-
Chinese
Native or bilingual proficiency
-
Cantonese
Professional working proficiency
Organizations
-
AACR
-
-
ASCO
-
-
ENDO
-
More activity by Ge (Gina)
-
We are pleased to announce that AR882 has received FDA Fast Track Designation for treating tophaceous gout. This designation will expedite the…
We are pleased to announce that AR882 has received FDA Fast Track Designation for treating tophaceous gout. This designation will expedite the…
Liked by Ge (Gina) Wei
-
Today, we are pleased to share several updates on our pipeline progress and report Q2 financial results. Read through highlights below and find full…
Today, we are pleased to share several updates on our pipeline progress and report Q2 financial results. Read through highlights below and find full…
Liked by Ge (Gina) Wei
-
Nurix Discloses its Clinical Inhibitor of CBL-B for Immuno-oncology Indications | https://lnkd.in/gcnRaJdC NX-1607, the first orally bioavailable…
Nurix Discloses its Clinical Inhibitor of CBL-B for Immuno-oncology Indications | https://lnkd.in/gcnRaJdC NX-1607, the first orally bioavailable…
Liked by Ge (Gina) Wei
-
Hi friends! I grew up loving the movies and have had a longtime dream to make movies one day that could be viewed on the big screen. I'm super…
Hi friends! I grew up loving the movies and have had a longtime dream to make movies one day that could be viewed on the big screen. I'm super…
Liked by Ge (Gina) Wei
-
What a way to kick off the 17th International Earth Science Olympiad! 🌍🎉 On August 8th, 136 students and 110 teachers from 35 countries & regions…
What a way to kick off the 17th International Earth Science Olympiad! 🌍🎉 On August 8th, 136 students and 110 teachers from 35 countries & regions…
Liked by Ge (Gina) Wei
-
Evexta Bio SA, a clinical-stage biotechnology company focused on developing first-in-class therapies in oncology, announces the appointment of Robert…
Evexta Bio SA, a clinical-stage biotechnology company focused on developing first-in-class therapies in oncology, announces the appointment of Robert…
Liked by Ge (Gina) Wei
-
What mysteries are you pondering, feline philosopher? 🌿🐾 As summer envelops Yannan Garden in lush greenery and deep tranquility, each moment…
What mysteries are you pondering, feline philosopher? 🌿🐾 As summer envelops Yannan Garden in lush greenery and deep tranquility, each moment…
Liked by Ge (Gina) Wei
-
"When I reach where the water ends, I sit down to watch the clouds rise." — Tang Dynasty poet Wang Wei #PKUinSummer 🎦: Nie Mingjun
"When I reach where the water ends, I sit down to watch the clouds rise." — Tang Dynasty poet Wang Wei #PKUinSummer 🎦: Nie Mingjun
Liked by Ge (Gina) Wei
-
#PKU new student Han Xu, a star of the Chinese squad at #Paris2024, is ready to slam dunk her way through the women's 5x5 basketball tournament. ⛹♀…
#PKU new student Han Xu, a star of the Chinese squad at #Paris2024, is ready to slam dunk her way through the women's 5x5 basketball tournament. ⛹♀…
Liked by Ge (Gina) Wei
-
“With gates open wide, #PKU’s spirit abides.” 🎬: Mao Bochun; Xu Yuqian #Admission #Admissionletter #Admissionnotice #PekingUniversity #Pekingers
“With gates open wide, #PKU’s spirit abides.” 🎬: Mao Bochun; Xu Yuqian #Admission #Admissionletter #Admissionnotice #PekingUniversity #Pekingers
Liked by Ge (Gina) Wei
-
In the U.S., lung cancers account for 1 in 5 of all cancer deaths. At Nurix, we’re using our targeted protein modulation platform to potentially…
In the U.S., lung cancers account for 1 in 5 of all cancer deaths. At Nurix, we’re using our targeted protein modulation platform to potentially…
Liked by Ge (Gina) Wei
-
Excited to share this Radiology paper published on July 30, showcasing theranostics as a powerful enabler in helping patients in need. The work…
Excited to share this Radiology paper published on July 30, showcasing theranostics as a powerful enabler in helping patients in need. The work…
Liked by Ge (Gina) Wei
-
Transposon Therapeutics, a biotechnology firm focused on creating innovative, orally administered treatments for neurodegenerative and age-related…
Transposon Therapeutics, a biotechnology firm focused on creating innovative, orally administered treatments for neurodegenerative and age-related…
Liked by Ge (Gina) Wei
-
In the latest episode of our #OnRarePodcast, Jonathan Fox, M.D., Ph.D., President and CMO of BridgeBio Cardiorenal, explains the differences of the…
In the latest episode of our #OnRarePodcast, Jonathan Fox, M.D., Ph.D., President and CMO of BridgeBio Cardiorenal, explains the differences of the…
Liked by Ge (Gina) Wei
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More